{"news_desk": "Editorial", "print_page": "22", "section_name": "Opinion", "subsection_name": null, "byline": {"contributor": "", "original": "By THE EDITORIAL BOARD", "person": [], "organization": "THE EDITORIAL BOARD"}, "abstract": "Editorial welcomes Obama administration's request that Congress allow Medicare officials to negotiate drug prices directly with manufacturers, in effort to bring transparency to process; expresses hope that states will do same, with bills in offing to impose new cost reporting procedures; contends manufacturers should be forced to either justify increasingly higher prices or restrain increases so Americans can buy drugs at affordable costs.", "type_of_material": "Editorial", "word_count": "659", "lead_paragraph": "The Obama administration and some states are tackling the lack of transparency and the rising costs.", "pub_date": "2015-05-05T00:00:00Z", "document_type": "article", "slideshow_credits": null, "headline": {"main": "Runaway Drug Prices", "content_kicker": "Editorial", "print_headline": "Runaway Drug Prices", "kicker": "Editorial"}, "snippet": "The Obama administration and some states are tackling the lack of transparency and the rising costs.", "multimedia": [{"height": 126, "url": "images/2015/05/05/opinion/05tue1web/05tue1web-thumbWide.jpg", "legacy": {"widewidth": "190", "wideheight": "126", "wide": "images/2015/05/05/opinion/05tue1web/05tue1web-thumbWide.jpg"}, "type": "image", "width": 190, "subtype": "wide"}, {"height": 400, "url": "images/2015/05/05/opinion/05tue1web/05tue1web-articleLarge.jpg", "legacy": {"xlargewidth": "600", "xlargeheight": "400", "xlarge": "images/2015/05/05/opinion/05tue1web/05tue1web-articleLarge.jpg"}, "type": "image", "width": 600, "subtype": "xlarge"}, {"height": 75, "url": "images/2015/05/05/opinion/05tue1web/05tue1web-thumbStandard.jpg", "legacy": {"thumbnailwidth": "75", "thumbnail": "images/2015/05/05/opinion/05tue1web/05tue1web-thumbStandard.jpg", "thumbnailheight": "75"}, "type": "image", "width": 75, "subtype": "thumbnail"}], "web_url": "http://www.nytimes.com/2015/05/05/opinion/runaway-drug-prices.html", "keywords": [{"rank": "1", "is_major": "Y", "value": "Editorials", "name": "subject"}, {"rank": "2", "is_major": "Y", "value": "Medicare", "name": "subject"}, {"rank": "3", "is_major": "Y", "value": "Drugs (Pharmaceuticals)", "name": "subject"}, {"rank": "4", "is_major": "N", "value": "Prices (Fares, Fees and Rates)", "name": "subject"}, {"rank": "5", "is_major": "N", "value": "Health Insurance and Managed Care", "name": "subject"}, {"rank": "6", "is_major": "N", "value": "Obama, Barack", "name": "persons"}, {"rank": "7", "is_major": "N", "value": "United States", "name": "glocations"}], "blog": [], "_id": "55486f7738f0d81a8df266c8", "source": "The New York Times"}